Rare diseases
Investigational molecules
Locations
Siemensdamm 65, Siemensstadt, 13627 Berlin, Germany
CRS Clinical Research Services Management GmbH in Berlin, Germany specialises in clinical trials of conditions such as Dermatitis atopic, Drug level, Psoriasis, Bacterial vaginosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in plaque psoriasis, focusing on innovative treatments for patients with moderate to severe conditions affecting special areas. The ongoing studies aim to enhance the efficacy and safety of new therapeutic agents, providing relief and improving the quality of life for those affected by this chronic skin condition.
Through rigorous clinical trials, the center contributes significantly to the understanding and management of plaque psoriasis, offering hope for more effective treatments.
Specializing in the treatment of moderate-to-severe pruritus associated with notalgia paresthetica, the center is dedicated to exploring the efficacy of novel oral medications. By evaluating different dosages and their impact on itch intensity, the research aims to identify optimal treatment strategies that can significantly alleviate symptoms for patients.
The center's commitment to advancing the understanding of pruritus and its management underscores its role as a leader in dermatological research and patient care.
Clinical trials currently enrolling participants at this site.
Study of chlorhexidine, metronidazole, and FB301 for the treatment of women with bacterial vaginosis
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 and Deucravacitinib for Adults with Moderate to Severe Plaque Psoriasis
GermanyA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
GermanyEffect of multiple doses of BI 1358894 on the pharmacokinetics of ethinylestradiol and drospirenone in healthy women
GermanyStudy of BI 1810631 oral bioavailability in healthy men under fed vs fasted conditions
GermanyStudy on the Effectiveness and Safety of Difelikefalin for Adults with Moderate-to-Severe Itching from Notalgia Paresthetica
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Plaque Psoriasis in Special Areas for Patients with Moderate to Severe Symptoms
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
